Stock CCEL CRYO-CELL INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cryo-Cell International, Inc.

Equities

CCEL

US2288951088

Market Closed - Nyse
Other stock markets
 21:10:00 14/05/2024 BST 		5-day change 1st Jan Change
9.19 USD +2.80% Intraday chart for Cryo-Cell International, Inc. +6.49% +59.83%
04-15 Cryo-Cell International, Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
03-25 Cryo-Cell International to Spin Off Celle Unit, Explore Strategic Alternatives; Shares Jump MT

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • For the past twelve months, EPS forecast has been revised upwards.

Weaknesses

  • The company has insufficient levels of profitability.
  • With an expected P/E ratio at 306.33 and 76.58 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
CRYO-CELL INTERNATIONAL, INC. Stock Cryo-Cell International, Inc.
+59.83% 74.48M -
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.08% 70.3B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+2.32% 27.46B
C+
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-7.08% 17.8B
B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+2.28% 17.46B
A-
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.93% 15.46B
A-
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+6.78% 13.49B
B-
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+8.14% 13.06B
A-
NATERA, INC. Stock Natera, Inc.
+68.45% 12.96B
C-
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+70.12% 12.56B
C+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. CCEL Stock
  4. Ratings Cryo-Cell International, Inc.